Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression
Treatment options for chronically aggressive individuals remain limited despite recent medical advances. Traditional pharmacological agents used to treat aggression, such as atypical antipsychotics, have limited efficacy and are often replete with dangerous side effects. The non-competitive NMDAR an...
| Автори: | , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
Frontiers Media S.A.
2022-06-01
|
| Серія: | Frontiers in Behavioral Neuroscience |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/fnbeh.2022.938044/full |